Abstract. Protein-bound polysaccharide K (PSK) is extracted and purified from Coriolus versicolor (CM101), and is used as an anti-cancer agent. In this study, focusing on the direct actions of PSK, we investigated whether PSK reaches tumor and immune tissues with its active structure remaining intact, and the direct action of PSK was evaluated by its antitumor effects against MethA fibrosarcomas implanted in immunodeficient NOD/SCID mice. The results obtained suggest that PSK reaches the tumor tissue in its active form and exhibits antitumor effects against MethA cells.
IntroductionProtein-bound polysaccharide-K (PSK) is a proteinpolysaccharide complex extracted from the cultured mycelia of Coriolus versicolor (strain CM101). In Japan, this compound is mainly used as an anti-cancer agent for postoperative gastric cancer and colorectal cancer in combination with chemotherapeutic agent. The molecular weight of PSK averages approximately 100,000, and varies over a wide range from 5,000 to 300,000. The main structural constituent is polysaccharide with the main chain linked by ß-D-(1➝4) bond and the side chains by ß-D-(1➝3) and ß-D-(1➝6) bonds.The antitumor effect of PSK is manifested by three major mechanisms of action: i) inhibition of cell proliferation (cytostatic effect); ii) neutralization of immunosuppressive substances; and iii) immunostimulatory activities (1-13).However, no data has hitherto demonstrated that the physiologically active structure of PSK is actually absorbed from bowel and reaches tumor and immune tissues. In addition, it remains unknown which moiety of the PSK molecule is responsible for these direct and indirect antitumor actions. One of the reasons is that PSK is not a compound with homogeneous structure, but is a mixture of glucan and protein complexes formed during the extraction process. Therefore isolation and structural determination of the active structure by conventional methods such as high performance liquid chromatography and mass spectral analysis are difficult. Furthermore, since the structure of its active site is unknown, there are difficulties in investigating the blood concentration and tumor tissue distribution of the compound after administration.Methods for the detection of PSK include the Limulus test that detects ß1-3 glucan or lipopolysaccharide (LPS) (unpublished data). However, since the Limulus test is positive not only for PSK but also for other polysaccharides containing ß1-3 glucan (such as laminarin and yeast glucan), it is not a specific detection method for PSK (unpublished data). Production of antibodies against PSK and the evaluation of these antibodies have also been reported (14). However, the rabbit anti-PSK polyclonal antibodies produced recognize all molecules containing ß1-3 glucan, ß1-4 glucan and ß1-6 glucan structures, and is therefore relatively low specificity for PSK. These antibodies are not appropriate for the detection of PSK with physiological activities (unpublished data).In the present study, we produced a monoclonal antibody against the ...